Appili Therapeutics Inc Class A (TSE:APLI) has released an update.
Appili Therapeutics Inc. is set to hold a special shareholder meeting to vote on the acquisition of the company by Aditxt Inc., where shareholders will receive a combination of cash and Aditxt stock per Appili share. This arrangement, recommended by Appili’s board, offers a significant premium on Appili’s recent trading price and is expected to accelerate the development of Appili’s infectious disease programs through enhanced capital access and commercialization support.
For further insights into TSE:APLI stock, check out TipRanks’ Stock Analysis page.
